MPC
49
3
ED
45
3
CMS
53
5
CAG
55
7
DTE
45
3
NVDA
46
-6
ORCL
50
-4
SE
69
-2
UNH
52
3
AIZ
78
3
AES
47
-3
SRE
45
7
SYF
65
-2
GRMN
45
-3
CL
51
4
TRV
52
3
RF
67
-2
DG
33
2
ETN
50
-7
MO
69
4
MPC
49
3
ED
45
3
CMS
53
5
CAG
55
7
DTE
45
3
NVDA
46
-6
ORCL
50
-4
SE
69
-2
UNH
52
3
AIZ
78
3
AES
47
-3
SRE
45
7
SYF
65
-2
GRMN
45
-3
CL
51
4
TRV
52
3
RF
67
-2
DG
33
2
ETN
50
-7
MO
69
4
Financhill
Back

Office Properties Income Trust Vs. Alnylam Pharmaceuticals Industry Stock Comparison

Sell
16

OPI
Office Properties Income Trust

Last Price:
$0.51
Seasonality Move:
-1.03%
Sell
41

ALNY
Alnylam Pharmaceuticals

Last Price:
$271.18
Seasonality Move:
7.6%
Sell
16
Office Properties Income Trust (OPI) is a Sell

Is Office Properties Income Trust a Buy, Sell or Hold?

  • The current Office Properties Income Trust [OPI] share price is $0.49. The Score for OPI is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
  • OPI is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
41
Alnylam Pharmaceuticals (ALNY) is a Sell

Is Alnylam Pharmaceuticals a Buy, Sell or Hold?

  • The current Alnylam Pharmaceuticals [ALNY] share price is $269.21. The Score for ALNY is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • ALNY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

OPI Stock Price Chart

What is Office Properties Income Trust's stock price today?

  • The Office Properties Income Trust share price today is $0.49
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and OPI is experiencing selling pressure, which indicates risk of future bearish movement.

ALNY Stock Price Chart

What is Alnylam Pharmaceuticals's stock price today?

  • The Alnylam Pharmaceuticals share price today is $269.21
    The current trend is moderately bullish and ALNY is experiencing selling pressure, which indicates risk of future bearish movement.

OPI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.1 Sell
Relative Strength Index (14 RSI): 24.29 Sell
Chaikin Money Flow: -654032 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.67 - 0.93) Sell
Bollinger Bands (100): (0.79 - 1.39) Sell

ALNY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 5.33 Buy
Relative Strength Index (14 RSI): 56.44 Buy
Chaikin Money Flow: -958699 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (238.07 - 265.67) Buy
Bollinger Bands (100): (240.5 - 271.04) Buy

OPI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.62 Sell
20-day SMA: 0.78 Sell
50-day SMA: 0.86 Sell
200-day SMA: 1.65 Sell
8-day EMA: 0.62 Sell
20-day EMA: 0.73 Sell
50-day EMA: 0.88 Sell
200-day EMA: 1.75 Sell

ALNY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 266.08 Buy
20-day SMA: 252.48 Buy
50-day SMA: 259.02 Buy
200-day SMA: 252.75 Buy
8-day EMA: 268.02 Buy
20-day EMA: 259.47 Buy
50-day EMA: 256.9 Buy
200-day EMA: 244.06 Buy

Office Properties Income Trust Earnings Growth & OPI Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.89 per share, and a decrease next year of $0.51 per share.

Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.91 per share, an increase next quarter of $0.05 per share, an increase this year of $1.08 per share, and an increase next year of $2.75 per share.

Office Properties Income Trust Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Alnylam Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):